SeqBiome CEO and co-founder Dr Marcus Claesson publish two large microbiome studies on inflammatory bowel disease in Nature Communications and Gut.
Read more in NutraIngredients.
SeqBiome CEO and co-founder Dr Marcus Claesson publish two large microbiome studies on inflammatory bowel disease in Nature Communications and Gut.
Read more in NutraIngredients.